Vivace Therapeutics to Unveil First Clinical Data for a Cancer Drug Targeting the Hippo Pathway

/PRNewswire/ -- Vivace Therapeutics, Inc., a small molecule discovery and development company developing first-in-class therapies targeting the Hippo pathway,...

Related Keywords

China ,Florida ,United States ,Wuxi ,Jiangsu ,American ,Tim Brons ,Timothya Yap ,Vivace Therapeutics Inc ,American Association For Cancer Research ,University Of Texas ,Prnewswire Vivace Therapeutics Inc ,Md Anderson Cancer Center ,Oral Presentation ,American Association ,Cancer Research ,Annual Meeting ,Cancer Center ,Rare Cancers ,Novel Targeted ,Vivace Therapeutics ,San Francisco Bay Area ,Canaan Partners ,Wuxi Healthcare Ventures ,Cenova Capital ,Sequoia Capital China ,Boxer Capital ,Strategic Partners ,Nc ,